About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Portland | 191 Studies

Clinical Trials Ovarian CancerPortland

Ovarian Cancer Clinical Trials in Portland

Find 191 clinical trials for ovarian cancer near Portland, Oregon. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 191 trials

RecruitingInvestigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian CancerThis study is researching an experimental drug called ubamatamab, also referred to as "study drug". The study is focused on participants who have advanced ovarian cancer.NCT06787612·Birmingham, Alabama and 55 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedStudy of ADCT-301 in Patients With Selected Advanced Solid TumorsThis study evaluates ADCT-301 in patients with Selected Advanced Solid Tumors.NCT03621982·Palo Alto, California and 8 others

CompletedIncidence of Cancer in Women at Increased Genetic Risk of Ovarian CancerThis clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer.NCT01139957·Birmingham, Alabama and 140 others

Active not recruitingPalbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialThis phase II ComboMATCH treatment trial evaluates the effectiveness of palbociclib and binimetinib in treating patients with RAS-mutated cancers.NCT05554367·Birmingham, Alabama and 264 others

TerminatedPhase 1/2a Study of SQ3370 in Patients With Advanced Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors.NCT04106492·Duarte, California and 9 others

Active not recruitingPhase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)A Phase I-II, First-in-Human Study of SKB264 (Sac-TMT; MK-2870) in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard…NCT04152499·Glendale, California and 108 others

CompletedGlycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)This is a Phase 1/2, first-in-human, open-label, dose escalation and dose-expansion study of E-602, administered alone and in combination with cemiplimab.NCT05259696·La Jolla, California and 12 others

CompletedDose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) proﬁles of RMC-4630 and cobimetinib in adult participants with…NCT03989115·Scottsdale, Arizona and 23 others

CompletedPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerDetermine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as monotherapy or in combination in…NCT02635672·Springdale, Arkansas and 15 others

CompletedCarboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003644·Birmingham, Alabama and 150 others

Active not recruitingA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid TumorsTScan Therapeutics is developing cellular therapies across multiple solid tumors in which autologous participant-derived engeneered T cells are engineered to express a T cell…NCT05973487·Scottsdale, Arizona and 20 others

RecruitingStudy of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)This clinical trial is designed to evaluate the efficacy and safety of T-DXd in combination with bevacizumab versus bevacizumab monotherapy as first-line maintenance therapy, in…NCT06819007·Burbank, California and 207 others

Active not recruitingA Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based ChemotherapyThis is a Phase 3, randomized, multinational, double-blind, dual placebo-controlled, 4-arm study evaluating rucaparib and nivolumab as maintenance treatment following response to…NCT03522246·Phoenix, Arizona and 237 others

RecruitingStudy to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionThe purpose of this study is to evaluate INCB123667 versus investigator's choice of chemotherapy in participants with platinum-resistant ovarian cancer with cyclin E1…NCT07214779·Anchorage, Alaska and 191 others

TerminatedA Study of SGN-STNV in Advanced Solid TumorsThis trial will look at a drug called SGN-STNV to find out whether it is safe for patients with solid tumors. It will study SGN-STNV to find out what its side effects are.NCT04665921·Los Angeles, California and 17 others

CompletedCarboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase III trial studies carboplatin, paclitaxel, and bevacizumab to see how well they work compared to carboplatin, paclitaxel, and placebo in treating patients…NCT00262847·Anniston, Alabama and 631 others

Active not recruitingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib AloneThis phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone in treating…NCT03660826·Birmingham, Alabama and 760 others

UnknownStudy of DPX-Survivac Therapy in Patients With Recurrent Ovarian CancerT cell activating therapy DPX-Survivac, low dose oral cyclophosphamide, and IDO1 inhibitor epacadostat will be tested together for the first time in patients with recurrent…NCT02785250·Palo Alto, California and 8 others

TerminatedSafety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal CancerThis 2-part, Phase 1/2 study will test investigational cancer drugs known as CRS-207, epacadostat (IDO), and pembrolizumab (pembro).NCT02575807·Scottsdale, Arizona and 11 others

TerminatedClinical Trial for Ovarian Cancer (OvaRex®)This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients.NCT00050375·Huntsville, Alabama and 61 others

PreviousPage 8 of 10Next

Other Conditions in Portland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia